The utilization of the RNA In Situ Hybridization Market within the drug development pipeline has become a strategic advantage for pharmaceutical companies. By providing visual evidence of how a drug candidate influences gene expression in specific tissue types, researchers can gain faster insights into therapeutic efficacy and potential toxicity. This accelerates the decision-making process...